Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tartour

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Biologie Aujourd'Hui|April 12, 2019
[Anti-cancer vaccines: What future in anti-cancer immunotherapy strategies?]Eric Tartour
ESMO Open|February 2, 2018
New therapeutic targets in the inflammatory microenvironmentEric Tartour
Medecine Sciences : M/S|September 8, 2025
[MHC-II deletion inibits melanoma growth in mice]Thi Tran, Eric Tartour
Microbes and Infection|June 22, 2006
Correspondence to Creydt VP et al., Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells, Microbes Infect. 8(2) (2006) 410-419Ludger Johannes, Eric Tartour
Toxins|March 24, 2022
STxB as an Antigen Delivery Tool for Mucosal VaccinationEric Tartour, Ludger Johannes
The Lancet. Respiratory Medicine|January 28, 2014
Lung cancer: potential targets for immunotherapyEric Tartour, Laurence Zitvogel
Frontiers in Immunology|June 14, 2019
Editorial: Tissue Resident Memory T CellsFathia Mami-Chouaib, Eric Tartour
Oncoimmunology|October 2, 2013
VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancerMagali Terme, Eric Tartour, Julien Taieb
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2015
Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer VaccinesMevyn Nizard, Hélène Roussel, Eric Tartour
Medecine Sciences : M/S|December 12, 2025
[Role of resident memory T cell subpopulations in anti-tumour vaccination and cancer immunotherapy]Léa Paolini, Thi Tran, Eric Tartour
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Biologie Aujourd'Hui|April 12, 2019
[Anti-cancer vaccines: What future in anti-cancer immunotherapy strategies?]Eric Tartour
ESMO Open|February 2, 2018
New therapeutic targets in the inflammatory microenvironmentEric Tartour
Medecine Sciences : M/S|September 8, 2025
[MHC-II deletion inibits melanoma growth in mice]Thi Tran, Eric Tartour
Microbes and Infection|June 22, 2006
Correspondence to Creydt VP et al., Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells, Microbes Infect. 8(2) (2006) 410-419Ludger Johannes, Eric Tartour
Toxins|March 24, 2022
STxB as an Antigen Delivery Tool for Mucosal VaccinationEric Tartour, Ludger Johannes
The Lancet. Respiratory Medicine|January 28, 2014
Lung cancer: potential targets for immunotherapyEric Tartour, Laurence Zitvogel
Frontiers in Immunology|June 14, 2019
Editorial: Tissue Resident Memory T CellsFathia Mami-Chouaib, Eric Tartour
Oncoimmunology|October 2, 2013
VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancerMagali Terme, Eric Tartour, Julien Taieb
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2015
Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer VaccinesMevyn Nizard, Hélène Roussel, Eric Tartour
Medecine Sciences : M/S|December 12, 2025
[Role of resident memory T cell subpopulations in anti-tumour vaccination and cancer immunotherapy]Léa Paolini, Thi Tran, Eric Tartour
Pageof 23